contract_awardAwarded Monday, July 20, 2026Analyzed

MENTAL HEALTH & SUBSTANCE ABUSE SERVICES, TENNESSEE DEPARTMENT OF: $95.1M Department of Health and Human Services Grant

Bullish

Summary

This $95.1M grant to the Tennessee Department of Mental Health and Substance Abuse Services funds opioid and stimulant use disorder prevention, treatment, and recovery programs across the state. As the recipient is a state agency, no publicly traded company is directly tied to this award, but the overall sector impact supports healthcare service providers and harm reduction supply vendors.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The contract is a state-level grant, not awarded to a public company, so no direct stock impact.
  • 2.Federal opioid response funding continues at significant levels, supporting healthcare sector tailwinds.
  • 3.Investors should monitor companies involved in naloxone, buprenorphine, and addiction treatment services for indirect benefits.

Market Implications

Since the recipient is a state agency, there is no direct market implication from this specific award. Broader sentiment for healthcare companies focused on substance use disorder treatments may be supported, but this contract alone does not move markets. Investors should look for contracts awarded directly to public companies in the behavioral health space, such as Acadia Healthcare or Universal Health Services, for clearer catalysts.

Full Analysis

The contract is a $95.1M project grant from SAMHSA to the Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS) for the TN SOR IV initiative, running from September 2024 to September 2027. The funding targets the opioid epidemic through expanded access to medication for opioid use disorder (MOUD), naloxone distribution, prevention training, and pilot programs for emergency department-initiated buprenorphine/naloxone and low-barrier MAT. Since the recipient is a state government entity, there is no direct public company beneficiary to attribute revenue impact. However, the award signals continued federal commitment to combating the opioid crisis, which benefits healthcare service providers, behavioral health companies, and pharmaceutical manufacturers of naloxone and buprenorphine products. Among related legislation, the 'Work Without Worry Act of 2026' (S5006) is neutral with impact 1/10 in Healthcare sector, indicating low legislative tailwind. No supply chain winners are identifiable from the contract description, as the grant flows through state-operated programs. Historically, similar SAMHSA state opioid response grants have supported steady funding for community health centers and medication-assisted treatment providers, but without direct stock price impact.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Contract Details

Recipient

MENTAL HEALTH & SUBSTANCE ABUSE SERVICES, TENNESSEE DEPARTMENT OF

Award Amount

$95,091,791

Awarding Agency

Department of Health and Human Services

Sub-Agency

Substance Abuse and Mental Health Services Administration

Contract Type

PROJECT GRANT (B)

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →